IL17A and Chronic mucocutaneous candidosis: Several studies have discovered that deficiency of IL-17RA, IL-17RC, IL-17F, and Act1, an essential component of IL-17 signaling, is associated with chronic mucocutaneous candidiasis in patients, suggesting a protective role of the IL-17 response [195,196,197].